Awasthi A, Katiyar H, Rungta S, Deep A, et al. Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naive non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial). PLoS One 2023;18:e0285725.
PMID: 37200346